Phosphoinsitide Regulation of the Golgi

高尔基体的磷酸肌醇调节

基本信息

  • 批准号:
    7465179
  • 负责人:
  • 金额:
    $ 31.81万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2004
  • 资助国家:
    美国
  • 起止时间:
    2004-04-01 至 2012-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Our overall hypothesis is that PI4KII? (phosphatidylinositol 4 kinase II?), which produces more than 50% of the phosphatidylinositol 4 phosphate (PI4P) in the Golgi, regulates Golgi functions through its localized production of PI4P. The PI4P itself establishes the Golgi's unique organelle identity by recruiting clathrin adapter proteins, such as AP-1, through the coincidence detection of Golgi PI4P and the Arf1 GTPase. In addition, PI4P, as substrate for production of phosphatidylinositol 4, 5 phosphate (PIP2), regulates membrane trafficking from the Golgi. We propose that the localization and enzymatic activity of PI4KII? in the Golgi and Golgi-derived organelles are regulated. Recent data from our lab and others show that the cell has at least two populations of PI4KII? that have different intrinsic catalytic activity and differential association with buoyant vs dense membranes fractions. We recently found that PI4KII?'s catalytic activity, its integral membrane association and partitioning into buoyant noncaveolar "rafts" are critically dependent on its palmitoylation. We therefore propose that these functions of PI4KII? are dynamically regulated by reversible palmitoylation of multiple cysteine residues in PI4KII?. We propose four Specific Aims to test this hypothesis. Aim I. Examine the role of PI4KII? in the generation of dynamic Golgi membrane trafficking carriers that contain PI4KII?. We will characterize these carriers and determine if their generation is dependent on the local synthesis of PI4P per se or downstream synthesis of PIP2. Aim II. Examine the role of PI4P in the recruitment of the AP-3 adaptor protein to endomembranes, to evaluate if it, like the related AP-1, binds target membranes through coincidence detection involving PI4P. Aim III. Determine how palmitoylation regulates PI4KII?. The palmitoylacyl transferase that palmitoylates PI4KII? will be identified and the effect of manipulating its expression on PI4KII? behavior will be examined. Aims I-III focus on the export of membranes from Golgi. Aim IV focuses on the recruitment of PI4KII? to the Golgi. Aim IV. Identify PI4KII?'s primary Golgi targeting motif and interactive proteins. We will identify PI4KII? motifs that are necessary and sufficient to direct PI4KII? to the Golgi prior to palmitoylation and will use an integrated proteomics approach to identify PI4KII? Golgi docking proteins and interactive partners. PUBLIC HEALTH RELEVANCE: Membrane phosphoinositides are major regulators of membrane trafficking, and both their synthesis and degradations are required for dynamic membrane movement and vesicle trafficking within the cell. The experiments in this proposal are designed to examine the role of a lipid kinase that makes an essential lipid in the Golgi. Disruption of this kinase or its misregulation will result in trafficking problems that can contribute to the development of multiple metabolic and neurodegenerative diseases due to improper trafficking of essential components within the cell. Problems with this and other related kinases have already been implicated in neurodegenerative diseases, including Alzheimer's disease.
描述(由申请人提供):我们的总体假设是 PI4KII? (磷脂酰肌醇 4 激酶 II?)在高尔基体中产生超过 50% 的磷脂酰肌醇 4 磷酸 (PI4P),通过其局部产生 PI4P 来调节高尔基体功能。 PI4P 本身通过高尔基体 PI4P 和 Arf1 GTPase 的一致性检测招募网格蛋白接头蛋白(例如 AP-1)来建立高尔基体独特的细胞器身份。此外,PI4P 作为产生磷脂酰肌醇 4, 5 磷酸 (PIP2) 的底物,调节高尔基体的膜运输。我们提出PI4KII 的定位和酶活性?在高尔基体和高尔基体衍生的细胞器中受到调节。我们实验室和其他实验室的最新数据表明,该细胞至少有两个 PI4KII 群体?具有不同的内在催化活性以及与浮力膜和致密膜部分的不同关联。我们最近发现 PI4KII 的催化活性、其完整的膜缔合和划分成浮力非空穴“筏”主要取决于其棕榈酰化。因此我们提出PI4KII的这些功能?通过 PI4KII? 中多个半胱氨酸残基的可逆棕榈酰化来动态调节。我们提出四个具体目标来检验这一假设。目标 I. 检查 PI4KII 的作用?包含 PI4KII 的动态高尔基体膜运输载体的生成?我们将表征这些载体并确定它们的生成是否依赖于 PI4P 本身的局部合成或 PIP2 的下游合成。目标二。检查 PI4P 在 AP-3 接头蛋白募集到内膜中的作用,以评估它是否像相关的 AP-1 一样,通过涉及 PI4P 的符合检测结合靶膜。目标三。确定棕榈酰化如何调节 PI4KII?棕榈酰基转移酶可棕榈酰化 PI4KII?将被识别并操纵其表达对 PI4KII 的影响?行为将受到检查。目标 I-III 重点关注高尔基体膜的输出。 Aim IV 重点招募 PI4KII?到高尔基体。目标四。识别 PI4KII?的主要高尔基体靶向基序和相互作用蛋白。我们会识别PI4KII吗?指导 PI4KII 所必需且充分的基序?在棕榈酰化之前先检测高尔基体并使用综合蛋白质组学方法来识别 PI4KII?高尔基对接蛋白和互动伙伴。 公共卫生相关性:膜磷酸肌醇是膜运输的主要调节剂,它们的合成和降解是细胞内动态膜运动和囊泡运输所必需的。该提案中的实验旨在检查脂质激酶的作用,该脂质激酶在高尔基体中形成必需脂质。这种激酶的破坏或其失调将导致运输问题,由于细胞内重要成分的运输不当,可能导致多种代谢和神经退行性疾病的发展。这种激酶和其他相关激酶的问题已经与神经退行性疾病有关,包括阿尔茨海默病。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HELEN L YIN其他文献

HELEN L YIN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HELEN L YIN', 18)}}的其他基金

Administrative Core
行政核心
  • 批准号:
    10663765
  • 财政年份:
    2023
  • 资助金额:
    $ 31.81万
  • 项目类别:
Mechanisms of Disease
疾病机制
  • 批准号:
    10189651
  • 财政年份:
    2019
  • 资助金额:
    $ 31.81万
  • 项目类别:
Mechanisms of Disease & Translational Science
疾病机制
  • 批准号:
    9064792
  • 财政年份:
    2014
  • 资助金额:
    $ 31.81万
  • 项目类别:
Mechanisms of Disease & Translational Science
疾病机制
  • 批准号:
    8663555
  • 财政年份:
    2014
  • 资助金额:
    $ 31.81万
  • 项目类别:
Mechanisms of Disease & Translational Science
疾病机制
  • 批准号:
    9328100
  • 财政年份:
    2014
  • 资助金额:
    $ 31.81万
  • 项目类别:
Phosphoinsitide Regulation of the Golgi
高尔基体的磷酸肌醇调节
  • 批准号:
    7931113
  • 财政年份:
    2009
  • 资助金额:
    $ 31.81万
  • 项目类别:
Phosphoinsitide Regulation of the Golgi
高尔基体的磷酸肌醇调节
  • 批准号:
    7048650
  • 财政年份:
    2004
  • 资助金额:
    $ 31.81万
  • 项目类别:
Phosphoinsitide Regulation of the Golgi
高尔基体的磷酸肌醇调节
  • 批准号:
    6875240
  • 财政年份:
    2004
  • 资助金额:
    $ 31.81万
  • 项目类别:
Phosphoinsitide Regulation of the Golgi
高尔基体的磷酸肌醇调节
  • 批准号:
    8061658
  • 财政年份:
    2004
  • 资助金额:
    $ 31.81万
  • 项目类别:
Phosphoinsitide Regulation of the Golgi
高尔基体的磷酸肌醇调节
  • 批准号:
    7215567
  • 财政年份:
    2004
  • 资助金额:
    $ 31.81万
  • 项目类别:

相似海外基金

Design of chemical probes for hedgehog acyltransferase
Hedgehog酰基转移酶化学探针的设计
  • 批准号:
    2600595
  • 财政年份:
    2022
  • 资助金额:
    $ 31.81万
  • 项目类别:
    Studentship
Identification of the glycolytic enzyme palmitoyl acyltransferase
糖酵解酶棕榈酰酰基转移酶的鉴定
  • 批准号:
    571756-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 31.81万
  • 项目类别:
    University Undergraduate Student Research Awards
The role of LYCAT acyltransferase in phagocytosis and immune function
LYCAT酰基转移酶在吞噬作用和免疫功能中的作用
  • 批准号:
    564899-2021
  • 财政年份:
    2021
  • 资助金额:
    $ 31.81万
  • 项目类别:
    University Undergraduate Student Research Awards
Targeting a Human Acyltransferase for Broad-Spectrum Antivirals
靶向人类酰基转移酶的广谱抗病毒药物
  • 批准号:
    10223496
  • 财政年份:
    2021
  • 资助金额:
    $ 31.81万
  • 项目类别:
Hedgehog acyltransferase : structure and function in health and disease
Hedgehog酰基转移酶:健康和疾病中的结构和功能
  • 批准号:
    BB/T01508X/1
  • 财政年份:
    2020
  • 资助金额:
    $ 31.81万
  • 项目类别:
    Research Grant
Protein acyltransferase mediated S-palmitoylation and its Importance in Innate Immunity and Lipid Metabolism.
蛋白质酰基转移酶介导的 S-棕榈酰化及其在先天免疫和脂质代谢中的重要性。
  • 批准号:
    401169
  • 财政年份:
    2019
  • 资助金额:
    $ 31.81万
  • 项目类别:
    Operating Grants
Is transcription factor TEAD a missing protein lysine fatty acyltransferase?
转录因子 TEAD 是缺失的蛋白质赖氨酸脂肪酰基转移酶吗?
  • 批准号:
    19K22271
  • 财政年份:
    2019
  • 资助金额:
    $ 31.81万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Basic research on the development of therapeutic agents for Alzheimer's disease using Acyl-CoA:cholesterol acyltransferase inhibitor
利用酰基辅酶A:胆固醇酰基转移酶抑制剂开发阿尔茨海默病治疗剂的基础研究
  • 批准号:
    19K07093
  • 财政年份:
    2019
  • 资助金额:
    $ 31.81万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Defining the Molecular Architecture for Transmembrane Acylation by a Membrane Bound O-Acyltransferase
定义膜结合 O-酰基转移酶跨膜酰化的分子结构
  • 批准号:
    10246913
  • 财政年份:
    2019
  • 资助金额:
    $ 31.81万
  • 项目类别:
Characterization of Xenopus laevis DHAP acyltransferase
非洲爪蟾 DHAP 酰基转移酶的表征
  • 批准号:
    540689-2019
  • 财政年份:
    2019
  • 资助金额:
    $ 31.81万
  • 项目类别:
    University Undergraduate Student Research Awards
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了